Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more
GKOS's Aroon Indicator triggered a bullish signal on June 04, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 307 similar instances where the Aroon Indicator showed a similar pattern. In of the 307 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for GKOS crossed bullishly above the 50-day moving average on May 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
GKOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GKOS as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for GKOS turned negative on June 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .
GKOS moved below its 50-day moving average on June 04, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.970) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (14.327) is also within normal values, averaging (42.393).
an ophthalmic medical device company
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MKOR | 25.08 | 0.95 | +3.96% |
Matthews Korea Active ETF | |||
VBND | 43.31 | 0.26 | +0.59% |
Vident U.S. Bond Strategy ETF | |||
QWLD | 131.80 | 0.12 | +0.09% |
SPDR® MSCI World StrategicFactors ETF | |||
XDOC | 31.08 | N/A | N/A |
Innovator US Equity Accelerated ETF Oct | |||
REGL | 80.76 | -0.77 | -0.94% |
ProShares S&P MidCap 400 Dividend Arst |
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ITGR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ITGR could also see price increases.
Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
---|---|---|---|---|
GKOS | 100% | -3.74% | ||
ITGR - GKOS | 50% Loosely correlated | +0.27% | ||
ISRG - GKOS | 49% Loosely correlated | +1.11% | ||
NTRA - GKOS | 48% Loosely correlated | +4.41% | ||
RDNT - GKOS | 48% Loosely correlated | -3.24% | ||
ALGN - GKOS | 46% Loosely correlated | +0.46% | ||
More |